Although overall we did not find significant differences in the molecular profile between patients with MPE and those without effusion, the presence of the EGFR gene mutation was one of the most frequent biomarkers found and was associated with a tendency towards tumor progression in the form of pleural metastases. This evidence concerns the gene EGFR and neoplasm.